Gemcitabine versus Gemcitabine Combined with Cisplatin Treatment Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Analysis

PURPOSE: Gemcitabine is the most active agent to treat unresectable pancreatic cancer. The superiority of combining other drugs with cisplatin is still controversial; therefore, we performed a retrospective analysis of gemcitabine versus gemcitabine combined with cisplatin to determine the treatment...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Choi, Jae-Hyuk, Oh, Sung Yong, Kwon, Hyuk-Chan, Kim, Jung Hwan, Lee, Jae Hoon, Lee, Suee, Lee, Dong Mee, Kim, Sung-Hyun, Rho, Myung Hwan, Kim, Young-Hoon, Rho, Mee-Sook, Kim, Hyo-Jin
Formato: Artigo
Lenguaje:Inglês
Publicado: Korean Cancer Association 2008
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2699081/
https://ncbi.nlm.nih.gov/pubmed/19688061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2008.40.1.22
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares